High-throughput DBS screening – from initial heel prick to final results
Early detection of metabolic and other inherited and rare disorders can improve the quality of life for at-risk babies and their families. And with the QSight® 210 MD system, we’re enabling expanded high-throughput screening – using just a single heel-prick dried blood spot (DBS) card. The QSight system delivers a unique combination of self-cleaning MS/MS instrumentation that provides exceptional system uptime, a simple three-step method-setup process, and easy-to-use database software that simplifies review and analysis – plus kits and reagents, training, and support.
It all comes together to enable you to screen thousands of samples per day, every day.